Cargando…

Melatonin as an Oncostatic Molecule Based on Its Anti-Aromatase Role in Breast Cancer

Breast cancer is the most common type of cancer. In the developmental stages of breast cancer, estrogens are strongly involved. As estrogen synthesis is regulated by the enzyme aromatase, targeting the activity of this enzyme represents a therapeutic option. The pineal hormone melatonin may exert a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jin, Yunho, Choi, Yoo Jin, Heo, Kyu, Park, Seong Joon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7795758/ https://www.ncbi.nlm.nih.gov/pubmed/33406787 http://dx.doi.org/10.3390/ijms22010438

Ejemplares similares

Oncostatic-Cytoprotective Effect of Melatonin and Other Bioactive Molecules: A Common Target in Mitochondrial Respiration
por: Pacini, Nicola, et al.
Publicado: (2016)

Melatonin is a potential oncostatic agent to inhibit HepG2 cell proliferation through multiple pathways
por: Ammar, Omar A., et al.
Publicado: (2022)

Rhus coriaria L. (Sumac) Demonstrates Oncostatic Activity in the Therapeutic and Preventive Model of Breast Carcinoma
por: Kubatka, Peter, et al.
Publicado: (2020)

Downregulation of complement factor H attenuates the stemness of MDA‑MB‑231 breast cancer cells via modulation of the ERK and p38 signaling pathways
por: Park, Soon Yong, et al.
Publicado: (2023)

G9a Knockdown Suppresses Cancer Aggressiveness by Facilitating Smad Protein Phosphorylation through Increasing BMP5 Expression in Luminal A Type Breast Cancer
por: Jin, Yunho, et al.
Publicado: (2022)

Role of melatonin combined with exercise as a switch-like regulator for circadian behavior in advanced osteoarthritic knee
por: Hong, Yunkyung, et al.
Publicado: (2017)

Role of aromatase inhibitors in breast cancer
por: Carpenter, R, et al.
Publicado: (2005)

Melatonin inhibits aromatase promoter expression by regulating cyclooxygenases expression and activity in breast cancer cells
por: Martínez-Campa, C, et al.
Publicado: (2009)

The Relationship between Autism Spectrum Disorder and Melatonin during Fetal Development
por: Jin, Yunho, et al.
Publicado: (2018)

Melatonin as a Novel Interventional Candidate for Fragile X Syndrome with Autism Spectrum Disorder in Humans
por: Won, Jinyoung, et al.
Publicado: (2017)

EpCAM peptide-primed dendritic cell vaccination confers significant anti-tumor immunity in hepatocellular carcinoma cells
por: Choi, Yoo Jin, et al.
Publicado: (2018)

Inhibitory effects of pharmacological doses of melatonin on aromatase activity and expression in rat glioma cells
por: González, A, et al.
Publicado: (2007)

What influences aromatase inhibitor continuation intention among breast cancer survivors?
por: Seo, Young Kyung, et al.
Publicado: (2021)

Anti-estrogenic and anti-aromatase activities of citrus peels major compounds in breast cancer
por: El-Kersh, Dina M., et al.
Publicado: (2021)

Melatonin: A Molecule for Reducing Breast Cancer Risk
por: González-González, Alicia, et al.
Publicado: (2018)

Beneficial Effects of Melatonin Combined with Exercise on Endogenous Neural Stem/Progenitor Cells Proliferation after Spinal Cord Injury
por: Lee, Youngjeon, et al.
Publicado: (2014)

Aromatase in human liver and its diseases
por: Hata, Shuko, et al.
Publicado: (2013)

Reconsidering Aromatase for Breast Cancer Treatment: New Roles for an Old Target
por: Caciolla, Jessica, et al.
Publicado: (2020)

Elevated Serum Melatonin under Constant Darkness Enhances Neural Repair in Spinal Cord Injury through Regulation of Circadian Clock Proteins Expression
por: Hong, Yunkyung, et al.
Publicado: (2019)

The Role of Aromatase Inhibitors in Male Prolactinoma
por: Akirov, Amit, et al.
Publicado: (2023)

Aromatase inhibitor strategies in metastatic breast cancer
por: McArthur, Heather L, et al.
Publicado: (2010)

Clinical utilities of aromatase inhibitors in breast cancer
por: Chumsri, Saranya
Publicado: (2015)

Aromatase inhibitors and their future role in post-menopausal women with early breast cancer.
por: Lønning, P. E.
Publicado: (1998)

Predicting the Benefit of Adjuvant Aromatase Inhibitor Therapy in Postmenopausal Breast Cancer Patients with Phosphorylated S6K1 Expression Status
por: Choi, Jihye, et al.
Publicado: (2019)

Evaluation of the anti-angiogenic action of melatonin in breast cancer
por: Jardim, Bruna V, et al.
Publicado: (2013)

Potential role of aromatase inhibitors in the treatment of endometriosis
por: Abu Hashim, Hatem
Publicado: (2014)

Anti-Amyloidogenic and Anti-Apoptotic Role of Melatonin in Alzheimer Disease
por: He, Hongwen, et al.
Publicado: (2010)

Long-term environmental exposure of darkness induces hyperandrogenism in PCOS via melatonin receptor 1A and aromatase reduction
por: Chu, Weiwei, et al.
Publicado: (2022)

Long-Term Effect of Aromatase Inhibition in Aromatase Excess Syndrome
por: Binder, Gerhard, et al.
Publicado: (2021)

Aromatase inhibitors in advanced breast cancer: there are efficacy differences
por: Bhatnagar, A S
Publicado: (2005)

Evolution of aromatase inhibitors as an endocrine treatment for breast cancer
por: Miller, WR
Publicado: (2006)

Survival Benefit of Zoledronic Acid in Postmenopausal Breast Cancer Patients Receiving Aromatase Inhibitors
por: Ahn, Sung Gwe, et al.
Publicado: (2014)

Local adipocytes enable estrogen-dependent breast cancer growth: Role of leptin and aromatase
por: Liu, Enbo, et al.
Publicado: (2013)

A Polymorphism at the 3′-UTR Region of the Aromatase Gene Is Associated with the Efficacy of the Aromatase Inhibitor, Anastrozole, in Metastatic Breast Carcinoma
por: Liu, Lei, et al.
Publicado: (2013)

Antitumor activity of Z-endoxifen in aromatase inhibitor-sensitive and aromatase inhibitor-resistant estrogen receptor-positive breast cancer
por: Jayaraman, Swaathi, et al.
Publicado: (2020)

Suppression of Osteoclastogenesis by Melatonin: A Melatonin Receptor-Independent Action
por: Kim, Hyung Joon, et al.
Publicado: (2017)

Anti-masculinization induced by aromatase inhibitors in adult female zebrafish
por: Chen, Lu, et al.
Publicado: (2020)

FRI077 Efficacy Of Anti-obesity Medications Among Breast Cancer Survivors Taking Aromatase Inhibitors
por: Fansa, Sima, et al.
Publicado: (2023)

Of sight, and insight into melatonin’s role in breast cancer?
por: Soares, José Maria, et al.
Publicado: (2023)

Aromatase inhibitor-associated musculoskeletal symptoms: incidence and associated factors
por: Park, Jin Young, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_nujq61felpg69lllbkvvlaaoc9